Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy

Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy

BackgroundChronic Chagas Cardiomyopathy (CCM) is characterized by a unique pathophysiology in which inflammatory, microvascular and neuroendocrine processes coalesce in the development of one of the most severe cardiomyopathies affecting humans. Despite significant advances in understanding the mole...

Full description

Bibliographic Details
Main Authors:	Sergio Alejandro Gómez-Ochoa, Paula Katherine Bautista-Niño, Lyda Z. Rojas, Lukas Hunziker, Taulant Muka, Luis E. Echeverría
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	chagas disease chronic chagas cardiomyopathy microRNAs echocardiography omics
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.922189/full

Similar Items

Circulating microRNAs as biomarkers of Chagas cardiomyopathy
by: Laura Antonietti, et al.
Published: (2023-12-01)

Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
by: Luis E. Echeverría, et al.
Published: (2021-11-01)

Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain
by: Sithu Win, et al.
Published: (2022-08-01)

Longitudinal Speckle Tracking Strain Abnormalities in Chagas Disease: A Systematic Review and Meta-Analysis
by: Sergio Alejandro Gómez-Ochoa, et al.
Published: (2022-01-01)

Circulating miR-146a as a possible candidate biomarker in the indeterminate phase of Chagas disease
by: Martha Alicia Ballinas-Verdugo, et al.
Published: (2021-07-01)

Treinamento com Exercício Físico e Doença de Chagas: Função Potencial dos MicroRNAs
by: Alex Cleber Improta-Caria, et al.
Published: (2021-07-01)

Determinants of minute ventilation-carbon dioxide production relationship in Chagas cardiomyopathy
by: Lucas Frois Fernandes Oliveira, et al.
Published: (2021-11-01)

Biomakers in Chronic Chagas Cardiomyopathy
by: Angela Braga Rodrigues, et al.
Published: (2022-08-01)

Late Gadolinium Enhancement by Cardiac Magnetic Resonance and Speckle Tracking Echocardiography in the Evaluation of Cardiac Complications in Chagas Cardiomyopathy: A Systematic Review
by: Laura-M Romero Acero, et al.
Published: (2022-09-01)

The Characterization of Cardiac Explants Reveals Unique Fibrosis Patterns and a Predominance of CD8+ T Cell Subpopulations in Patients with Chronic Chagas Cardiomyopathy
by: Martha Lucía Díaz, et al.
Published: (2022-11-01)

Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta‐analysis
by: Sindhu Chadalawada, et al.
Published: (2021-12-01)

Global, Regional, and National Trends of Chagas Disease from 1990 to 2019: Comprehensive Analysis of the Global Burden of Disease Study
by: Sergio Alejandro Gómez-Ochoa, et al.
Published: (2022-08-01)

WHF Recommendations for the Use of Echocardiography in Chagas Disease
by: Kate Ralston, et al.
Published: (2023-06-01)

Immunopathology of cardiomyopathy in the experimental Chagas disease
by: Milena BP Soares, et al.
Published: (1999-09-01)

The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters
by: Maria V. Pisklova, et al.
Published: (2023-05-01)

Metabolomic Profiling of End-Stage Heart Failure Secondary to Chronic Chagas Cardiomyopathy
by: Martha Lucía Díaz, et al.
Published: (2022-09-01)

Chronic Heart Disease after Treatment of Oral Acute Chagas Disease
by: Andrei Fornanciari Antunes, et al.

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study
by: Paula Simplício da Silva, et al.
Published: (2017-06-01)

Exploring the Historical Background and Clinical Implications of Electrocardiogram in the Context of Chagas Disease Research
by: Alejandro Marcel Hasslocher-Moreno, et al.
Published: (2023-12-01)

Exercise tests in Chagas cardiomyopathy: an overview of functional evaluation, prognostic significance, and current challenges
by: Henrique Silveira Costa, et al.
Published: (2020-07-01)

The Burden of Chagas Disease in the Contemporary World: The RAISE Study
by: Antonio Luiz Pinho Ribeiro, et al.
Published: (2024-01-01)

Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure
by: Isis G. Montalvo-Ocotoxtle, et al.
Published: (2022-12-01)

Preliminary study between Y chromosome haplogroups and chagasic cardiomyopathy manifestations in patients with Chagas disease
by: Oscar Lassen, et al.
Published: (2020-11-01)

Histopathological Correlates of Global and Segmental Left Ventricular Systolic Dysfunction in Experimental Chronic Chagas Cardiomyopathy
by: Luciano Fonseca Lemos de Oliveira, et al.
Published: (2016-01-01)

Occurrence of Stroke and Reduced Ejection Fraction in Patients with Chagas Disease
by: Elieusa e Silva Sampaio, et al.

Risk Score for Predicting 2‐Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi‐Trop Cohort Study
by: Claudia Di Lorenzo Oliveira, et al.
Published: (2020-03-01)

Blood DNA methylation marks discriminate Chagas cardiomyopathy disease clinical forms
by: Pauline Brochet, et al.
Published: (2022-09-01)

Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood
by: Marisa Liliana Fernández, et al.

Assessment of syndecan-4 expression in the hearts of Trypanosoma cruzi-infected mice and human subjects with chronic Chagas disease cardiomyopathy
by: Ticiana Ferreira Larocca, et al.
Published: (2018-12-01)

Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death
by: Antonia Pino-Marín, et al.
Published: (2021-04-01)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
by: Enrica Chiti, et al.
Published: (2021-09-01)

Mitochondrial DNA Haplogroups and Variants Predispose to Chagas Disease Cardiomyopathy
by: Frédéric Gallardo, et al.
Published: (2023-12-01)

Ethiological treatment of acute and chronic Chagas' heart disease
by: Abílio Augusto Fragata Filho, et al.

Dual chamber pacemaker implantation in woman with twin pregnancy and Chagas cardiomyopathy guided by 2D transthoracic echocardiography
by: Paul M. Preza, et al.
Published: (2022-01-01)

CD14 genotype and functional dichotomy of CD14+ and CD14- cells are associated with activated immune response and development of Chagas dilated cardiomyopathy
by: Germano Carneiro Costa, et al.

Parasitic Load Correlates With Left Ventricular Dysfunction in Patients With Chronic Chagas Cardiomyopathy
by: Maykon Tavares de Oliveira, et al.
Published: (2021-09-01)

Immunosuppressive drugs as a tool to explore immunopathology in experimental Chagas disease
by: KS Calabrese
Published: (1999-09-01)

Death due to acute Chagas -related myocarditis in a child: a case report
by: Theresa Cristina Cardoso da Silva, et al.
Published: (2020-04-01)

Prevalence and determinants of depressive symptoms in patients with Chagas cardiomyopathy and predominantly preserved cardiac function
by: Whesley Tanor Silva, et al.
Published: (2020-11-01)

Acometimento cardíaco em Casos de Doença de Chagas Aguda da Amazônia Cardiac involvement in Acute Chagas' Disease Cases in the Amazon region
by: João Marcos Barbosa-Ferreira, et al.
Published: (2010-06-01)